Advertisement
Advertisement

RCKT

RCKT logo

Rocket Pharmaceuticals, Inc. Common Stock

3.84
USD
Sponsored
0.00
0.00%
Jul 03, 09:30 UTC -4
Closed
exchange

After-Market

3.76

-0.08
-2.08%

Rocket Pharmaceuticals, Inc. Common Stock Profile

About

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States.

Info & Links

CEO

Gaurav Shah

Headquarters

9 Cedarbrook Drive
Cranbury, NJ 08512, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.rocketpharma.com

Auditor

EisnerAmper LLP

Share holders

33

Employees

202

Rocket Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

410.57M

Enterprise Value

382.23M

Enterprise Value/EBITDA(ttm)

-1.86

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-64.74%

Return on Invested Capital(ttm)

-62.12%

Return on Assets(ttm)

-55.24%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-205.43M

Net Income Available to Common(ttm)

-209.38M

Diluted EPS(ttm)

-2.01

Share Statistics

Beta (5Y Monthly)

0.57

52-Week Change

32.41%

S&P 500 52-Week Change

20.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

109.19M

Dividend Yield

0.00%

Float4

82.10M

% Held by Insiders

24.76%

% Held by Institutions

98.39%

Balance Sheet

Total Cash(mrq)

144.38M

Total Cash Per Share(mrq)

1.32

Total Debt(mrq)

21.27M

Total Debt/Equity(mrq)

7.67%

Current Ratio(mrq)

6.38%

Quick Ratio(mrq)

6.38%

Book Value Per Share(mrq)

2.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.71

Free Cash Flow(ytd)

-190.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement